Antibody response following the third and fourth SARS-CoV-2 vaccine dose in individuals with common variable immunodeficiency.

Front Immunol · 2022 · PMC9366053 · PMID 35967433

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

borderline significantp = 0.080so close (0.05 < p ≤ 0.1)

One month after the third and fourth dose, the levels were 226 BAU/ml (IQR: 7.0; 294 BAU/ml) and 433 BAU/ml (IQR: 326; 798 BAU/ml) with the increase being borderline significant (193 BAU/ml, 95% CI: −22; 569 BAU/ml, p = 0.080).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.